1. Quality-of-Life Assessment in Small Cell Lung Cancer

   • Peter Fayers

   Leading Article 13 November 2012 Pages: 181 - 188

2. Economic Constraints and Prescribing Patterns in New Zealand

   • Gavin S. M. Kellaway

   Leading Article 13 November 2012 Pages: 189 - 197

3. Review of Cost-Benefit Analyses of Influenza Vaccine

   • Jose Perez-Tirse
   • Peter A. Gross

   Review Article 13 November 2012 Pages: 198 - 206

4. Economic Evaluation of Treatments for Respiratory Disease

   • Stirling Bryan
   • Martin J. Buxton

   Review Article 13 November 2012 Pages: 207 - 218

5. Prescription Cost Sharing

   • Richard A. Levy

   Review Article 13 November 2012 Pages: 219 - 237

6. Consumption of Antibiotics in Sweden, 1975 to 1992

   • S. Ragnar Norrby

   Original Research Article 13 November 2012 Pages: 238 - 244

7. Spreadsheet Software Program to Analyse Costs Beyond Drug Acquisition Price

   • Joseph A. Paladino

   Current Comment 13 November 2012 Pages: 245 - 246

8. Cost of Pharmaceutical Services

   • Charles Normand

   Current Comment 13 November 2012 Pages: 246 - 248

9. HA-1A in Gram-Negative Sepsis

   • M. Jennings

   Current Comment 13 November 2012 Pages: 248 - 249

10. Costs of Asthma

    • Paul Hansen

    Current Comment 13 November 2012 Pages: 249 - 251

11. Defining Quality of Life

    • Frances Quirk
    • P. W. Jones
    • Michael E. Hyland

    Correspondence 13 November 2012 Pages: 252 - 257